Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.66 is 24% below its 4-year average of 0.87, near the low end of its 4-year range (0.55–1.68).
As of the fiscal period ended Tuesday, June 30, 2026. 3.20% below its 12-month average of 0.68.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.66.
QUICK RATIO (ACID-TEST)
0.66
QUICK RATIO (ACID-TEST) AVG TTM
0.68
QUICK RATIO (ACID-TEST) AVG 3Y
0.72
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-3.20%
CURRENT VS 3Y AVG
-8.15%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-80.23%
vs the sector median at left
Indivior Pharmaceuticals Inc
Market Cap
$4.44B
Quick Ratio (Acid-Test)
0.66
TTM Avg
0.68
3Y Avg
0.72
5Y Avg
N/A
Market Cap
$4.43B
Quick Ratio (Acid-Test)
5.08
TTM Avg
3.83
3Y Avg
4.06
5Y Avg
4.06
Market Cap
$4.39B
Quick Ratio (Acid-Test)
4.68
TTM Avg
3.02
3Y Avg
3.88
5Y Avg
4.28
Market Cap
$4.30B
Quick Ratio (Acid-Test)
16.24
TTM Avg
19.89
3Y Avg
20.20
5Y Avg
22.94
Market Cap
$4.65B
Quick Ratio (Acid-Test)
0.98
TTM Avg
1.08
3Y Avg
1.21
5Y Avg
1.19
Market Cap
$4.68B
Quick Ratio (Acid-Test)
11.31
TTM Avg
9.52
3Y Avg
6.89
5Y Avg
6.89
Market Cap
$4.69B
Quick Ratio (Acid-Test)
1.38
TTM Avg
1.51
3Y Avg
1.37
5Y Avg
1.40
Market Cap
$4.69B
Quick Ratio (Acid-Test)
6.95
TTM Avg
6.77
3Y Avg
6.23
5Y Avg
10.87
Market Cap
$4.73B
Quick Ratio (Acid-Test)
26.10
TTM Avg
14.27
3Y Avg
14.23
5Y Avg
14.47
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Indivior Pharmaceuticals Inc (INDV) | $4.44B | 0.66 | 0.68 | 0.72 | N/A |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.43B | 5.08 | 3.83 | 4.06 | 4.06 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.39B | 4.68 | 3.02 | 3.88 | 4.28 |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.30B | 16.24 | 19.89 | 20.20 | 22.94 |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 0.98 | 1.08 | 1.21 | 1.19 |
| BillionToOne, Inc. (BLLN)vs › | $4.68B | 11.31 | 9.52 | 6.89 | 6.89 |
| LifeStance Health Group, Inc. (LFST)vs › | $4.69B | 1.38 | 1.51 | 1.37 | 1.40 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.69B | 6.95 | 6.77 | 6.23 | 10.87 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.73B | 26.10 | 14.27 | 14.23 | 14.47 |
| LivaNova PLC (LIVN)vs › | $4.13B | 1.21 | 1.83 | 2.18 | 1.91 |
Quick Ratio
0.66
Excludes inventory
Current Ratio
0.84
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.66 |
| 2026-03-31 | 0.66 |
| 2025-12-31 | 0.55 |
| 2025-09-30 | 0.79 |
| 2025-06-30 | 0.76 |
| 2025-03-31 | 0.72 |
| 2024-12-31 | 0.70 |
| 2024-09-30 | 0.65 |
| 2024-06-30 | 0.68 |
| 2024-03-31 | 0.74 |
| 2023-12-31 | 0.88 |
| 2023-09-30 | 0.87 |
| 2023-06-30 | 0.99 |
| 2023-03-31 | 0.96 |
| 2022-12-31 | 1.12 |
| 2022-09-30 | 1.56 |
| 2022-06-30 | 1.58 |
| 2022-03-31 | 1.61 |
| 2021-12-31 | 1.68 |
